Maria Mullet
Acute Care · Chardon, OHNPI 1528794773
Payments from drug & device makers
Across 83 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$310
- Scpharmaceuticals Inc.$230
- E.r. Squibb & Sons, L.L.C.$174
- Novo Nordisk$143
- Impulse Dynamics (USA) Inc.$97
- Lexicon Pharmaceuticals, Inc.$95
- plus $640 from 19 others
What the payments were for
- Food & beverage$1,67599%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $310 |
| Scpharmaceuticals Inc. | 12 | $230 |
| E.r. Squibb & Sons, L.L.C. | 9 | $174 |
| Novo Nordisk | 6 | $143 |
| Impulse Dynamics (USA) Inc. | 5 | $97 |
| Lexicon Pharmaceuticals, Inc. | 4 | $95 |
| Pfizer | 5 | $92 |
| Azurity Pharmaceuticals, Inc. | 4 | $72 |
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim | 3 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Novartis | 2 | $32 |
| Merck | 2 | $30 |
| Bridgebio Pharma, Inc. | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Medtronic | 1 | $17 |
| Mannkind Corporation | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Amgen | 1 | $15 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$121
How this compares
$1,688 in reported general payments places this provider in the 85th percentile of 1,101 acute care providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dofetilide | 11 | $513 |
Paid to pharmacies, not to this prescriber.
Other acute care in Chardon
- Andrea RobinsonCleveland$149K
- Brittney BrowneMonroe$142K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
- Holly McKibbenColumbus$23K
- Jody HussBlue Ash$13K
- Julie LurieCincinnati$13K
- Susan BrooksMount Vernon$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.